ANI PHARMACEUTICALS, INC
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.1M | $3.9M | $15.4M | $28.7M | $301.0K | $-1.5M | $-51.6M | $-46.2M |
| Depreciation & Amortization | $27.9M | $22.3M | $6.9M | $3.9M | $1.1M | $567.0K | $148.2K | $168.0K |
| Depreciation | $1.2M | $900.0K | $700.0K | $600.0K | $500.0K | $517.0K | — | — |
| Amortization | $26.7M | $21.4M | $6.2M | $3.3M | $600.0K | $50.0K | — | — |
| Stock-Based Compensation | $6.1M | $6.1M | $3.9M | $3.4M | $36.0K | $0 | $1.2M | $992.8K |
| Net Cash from Operating Activities | $39.4M | $27.5M | $17.3M | $22.0M | $-5.5M | $-137.0K | $-47.9M | $-40.1M |
| Investing Activities | ||||||||
| Capital Expenditures | $10.4M | $4.6M | $2.2M | $1.1M | $191.0K | $292.0K | $719.9K | $63.4K |
| Business Acquisitions | $0 | $0 | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-108.0M | $-149.1M | $-32.7M | $-35.8M | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $0 | $2.5M | $0 | $0 | $433.0K | $0 | — | — |
| Net Cash from Financing Activities | $72.4M | $-729.0K | $1.1M | $171.7M | $-3.7M | $440.0K | — | — |
| Net Change in Cash | — | $-127.3M | $-14.4M | $157.9M | $11.1M | $11.0K | — | — |
| Free Cash Flow | $29.1M | $22.9M | $15.1M | $20.9M | $-5.7M | $-429.0K | $-48.6M | $-40.2M |